Kerala Ayurveda Limited's Board of Directors concluded their meeting on February 12, 2026, approving significant financial results and strategic corporate actions. The board meeting, which commenced at 12:00 PM and concluded at 3:30 PM, addressed key agenda items including quarterly financial results and major equity transactions.

Board Meeting Outcomes

The board approved several critical matters during their February 12, 2026 meeting:

Financial Performance Q3FY26

The company's unaudited financial results for the quarter and nine months ended December 31, 2025 show mixed performance across standalone and consolidated operations:

Standalone Results

Consolidated Results

Preferential Issue Details

The board approved a two-tranche preferential issue totaling 9,34,887 equity shares:

Tranche 1: Loan Conversion

Tranche 2: Subsidiary Acquisition

Ayurvedagram Acquisition Strategy

The company approved acquiring the remaining 26% stake in Ayurvedagram Heritage Wellness Centre Private Limited, making it a wholly owned subsidiary. Ayurvedagram's recent financial performance shows:

Regulatory Compliance and Next Steps

The company has scheduled an Extraordinary General Meeting on March 14, 2026, to seek shareholder approval for the preferential issues. The relevant date for determining the floor price has been set as February 12, 2026, in accordance with SEBI (ICDR) Regulations, 2018.

The Nomination and Remuneration Committee also approved granting 12,868 stock options under the Kerala Ayurveda Employee Restricted Stock Unit Plan 2023 to eligible employees at ₹10 per option, exercisable within one year.

Kerala Ayurveda has received a settlement order from the Securities and Exchange Board of India (SEBI), marking a significant regulatory development for the company.

Regulatory Settlement

The company has formally received the settlement order from SEBI, India's capital markets regulator. Settlement orders represent a mechanism through which regulatory matters are resolved between companies and SEBI without proceeding through the complete adjudication process.

Settlement Process

SEBI's settlement mechanism allows entities to resolve regulatory issues by agreeing to specific terms and conditions. This process typically involves the payment of settlement amounts and compliance with prescribed conditions, enabling companies to avoid prolonged regulatory proceedings.

Company Status

With the receipt of this settlement order, Kerala Ayurveda has formally concluded its regulatory matter with SEBI. The settlement represents the completion of the regulatory process between the company and the market regulator.